The Full Wiki

More info on Volinanserin

Volinanserin: Wikis

Advertisements

Note: Many of our articles have direct quotes from sources you can cite, within the Wikipedia article! This article doesn't yet, but we're working on it! See more info or our list of citable articles.

Encyclopedia

From Wikipedia, the free encyclopedia

Volinanserin
Systematic (IUPAC) name
(R)-(2,3-dimethoxyphenyl)-[1-[2-(4-fluorophenyl)ethyl]piperidin-4-yl]methanol
Identifiers
CAS number 139290-65-6
ATC code none
PubChem 5311271
Chemical data
Formula C 22H28FNO3  
Mol. mass 373.460 g/mol
SMILES eMolecules & PubChem
Pharmacokinetic data
Bioavailability  ?
Metabolism  ?
Half life  ?
Excretion  ?
Therapeutic considerations
Pregnancy cat.  ?
Legal status
Routes  ?

Volinanserin (MDL-100,907, M100907) is a psychoactive drug and research chemical which acts as a highly selective 5-HT2A receptor antagonist. It is widely used in scientific research to investigate the function of the 5-HT2A receptor.[1][2][3] It is also being investigated as a potential antipsychotic, antidepressant and treatment for insomnia.[4][5][6]

References

  1. ^ Schmidt CJ, Fadayel GM, Sullivan CK, Taylor VL (November 1992). "5-HT2 receptors exert a state-dependent regulation of dopaminergic function: studies with MDL 100,907 and the amphetamine analogue, 3,4-methylenedioxymethamphetamine". European Journal of Pharmacology 223 (1): 65–74. PMID 1362159.  
  2. ^ Herth MM, Kramer V, Piel M, Palner M, Riss PJ, Knudsen GM, Rösch F (April 2009). "Synthesis and in vitro affinities of various MDL 100907 derivatives as potential 18F-radioligands for 5-HT2A receptor imaging with PET". Bioorganic & Medicinal Chemistry 17 (8): 2989–3002. doi:10.1016/j.bmc.2009.03.021. PMID 19329329.  
  3. ^ Nic Dhonnchadha BA, Fox RG, Stutz SJ, Rice KC, Cunningham KA (April 2009). "Blockade of the serotonin 5-HT2A receptor suppresses cue-evoked reinstatement of cocaine-seeking behavior in a rat self-administration model". Behavioral Neuroscience 123 (2): 382–96. doi:10.1037/a0014592. PMID 19331461.  
  4. ^ Offord SJ, Wong DF, Nyberg S (August 1999). "The role of positron emission tomography in the drug development of M100907, a putative antipsychotic with a novel mechanism of action". Journal of Clinical Pharmacology Suppl: 17S–24S. PMID 10434243.  
  5. ^ Marek GJ, Martin-Ruiz R, Abo A, Artigas F (December 2005). "The selective 5-HT2A receptor antagonist M100907 enhances antidepressant-like behavioral effects of the SSRI fluoxetine". Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology 30 (12): 2205–15. doi:10.1038/sj.npp.1300762. PMID 15886717.  
  6. ^ Teegarden BR, Al Shamma H, Xiong Y (2008). "5-HT(2A) inverse-agonists for the treatment of insomnia". Current Topics in Medicinal Chemistry 8 (11): 969–76. PMID 18673166.  
Advertisements

Advertisements






Got something to say? Make a comment.
Your name
Your email address
Message